GlassScriptPhysician profile
Nikola C Conrad
NPI 1013279371
$996.18
in general payments reported to CMS, 2019-2025
17 companies · $574 in 2025
The $574 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.93 · 2022: $73.63 · 2023: $180 · 2024: $125 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.08 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $386.19 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $173.37 | 2021-2025 | Vraylar |
| Vivus LLC | $120.29 | 2025 | Qsymia |
| Lilly USA, LLC | $44.18 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
| Sanofi Pasteur INC. | $42.72 | 2022-2023 | |
| Organon LLC | $29.83 | 2024 | |
| Pfizer INC. | $26.68 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $25.62 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.90 | 2023 | |
| Abbott Laboratories | $18.24 | 2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $17.39 | 2023 | Vaxelis, Gardasil 9, Rotateq |
| Amgen INC. | $16.61 | 2021 | |
| Shield Therapeutics INC | $16.35 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.38 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.77 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $14.73 | 2024 | Yupelri |
| Incyte Corporation | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikola Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.